These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35743323)

  • 21. Vanishing Bile Duct Syndrome Associated With Estrogen.
    Benfield J; Shah RA; Grider DJ; Sahebjam F
    ACG Case Rep J; 2022 May; 9(5):e00776. PubMed ID: 35919669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.
    Zhao Z; Bao L; Yu X; Zhu C; Xu J; Wang Y; Yin M; Li Y; Li W
    Medicine (Baltimore); 2017 Sep; 96(36):e8009. PubMed ID: 28885366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vanishing Bile Duct Syndrome Associated With Non-Hodgkin's Lymphoma and Hepatitis E Virus Infection.
    Zafar M; Farooq M; Butler-Manuel W; Khattak MF; Rana UI; Muhammad T; Hawley I; Whitehead M; Toqeer M
    Cureus; 2022 Jan; 14(1):e21328. PubMed ID: 35070583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report.
    Patodiya B; Ramani VK; Rao PN; Sharma M; Patodiya S; Reddy DN
    SAGE Open Med Case Rep; 2023; 11():2050313X231208968. PubMed ID: 37954540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma].
    Córdoba Iturriagagoitia A; Iñarrairaegui Bastarrica M; Pérez de Equiza E; Zozaya Urmeneta JM; Martínez-Peñuela JM; Beloqui Pérez R
    Gastroenterol Hepatol; 2005 May; 28(5):275-8. PubMed ID: 15871809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
    Yeh P; Lokan J; Anantharajah A; Grigg A
    Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.
    Shionoya K; Kobayashi M; Kako M; Masuda S; Makazu M; Koizumi K
    Intern Med; 2024 Jun; 63(12):1719-1723. PubMed ID: 37952956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vanishing bile duct syndrome: a rare cause of jaundice in Hodgkin's lymphoma.
    Amer S; Muqeetadnan M; Rahman A; Nusrat S; Hassan S
    Turk J Gastroenterol; 2013; 24(5):444-6. PubMed ID: 24557970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.
    White JC; Appleman S
    Pediatrics; 2014 Oct; 134(4):e1194-8. PubMed ID: 25246624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report.
    Nwaesei AS; Moye-Dickerson PM; Dretler RH
    J Pharm Pract; 2021 Apr; 34(2):319-324. PubMed ID: 31451051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
    Kochar R; Nevah MI; Lukens FJ; Fallon MB; Machicao VI
    World J Gastroenterol; 2010 Jul; 16(26):3335-8. PubMed ID: 20614492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
    Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
    Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
    Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
    BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute vanishing bile duct syndrome after the use of ibuprofen.
    Basturk A; Artan R; Yılmaz A; Gelen MT; Duman O
    Arab J Gastroenterol; 2016 Sep; 17(3):137-139. PubMed ID: 27658326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events.
    Ishitsuka K; Yokoyama Y; Baba N; Matsuoka R; Sakamoto N; Sakamoto T; Kusakabe M; Kato T; Kurita N; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    J Clin Exp Hematop; 2022 Sep; 62(3):154-157. PubMed ID: 35831099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis.
    Wang J; Wang S; Wu C; Deng Z
    Infection; 2024 Jun; 52(3):891-899. PubMed ID: 37996645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.